Development of test panel of beta-lactamases expressed in a common Escherichia coli host background for evaluation of new beta-lactam antibiotics
Open Access
- 1 February 1995
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 39 (2) , 308-313
- https://doi.org/10.1128/aac.39.2.308
Abstract
A test panel of 35 different beta-lactamases expressed in a common Escherichia coli host was created to compare the effect that each beta-lactamase had on susceptibility to various beta-lactam antibiotics. A comparison of the MICs obtained with this panel generally reflected differences in the substrate profiles of the various beta-lactamases examined. In addition, several strains of the panel were subjected to selection with porin-specific bacteriophages to obtain mutants lacking either the OmpC or OmpF porin protein. A mutation in either OmpC or OmpF did change the susceptibilities of certain strains expressing beta-lactamase to certain beta-lactam antibiotics. However, the loss of a single porin did not predictably alter susceptibility to any given beta-lactam drug. This panel of strains producing various beta-lactamases was found to be a useful tool for comparing the effects of different beta-lactamases and outer membrane permeability upon susceptibility to beta-lactam drugs.Keywords
This publication has 50 references indexed in Scilit:
- -Lactamases of Gram-Negative Bacteria: New Challenges for New DrugsClinical Infectious Diseases, 1992
- Novel transferable extended-spectrum β-lactamase (SHV-6) from Klebsiella pneumoniae conferring selective resistance to ceftazidimeFEMS Microbiology Letters, 1991
- A Novel Chromosomal TEM Derivative and Alterations in Outer Membrane Proteins Together Mediate Selective Ceftazidime Resistance in Escherichia coliThe Journal of Infectious Diseases, 1990
- Activity of cefepime, ceftazidime, and ceftizoxime against mutants of Enterobacteriaceae and Pseudomonas aeruginosa derepressed for Class I β-lactamseJournal of Antimicrobial Chemotherapy, 1989
- Dissemination in five French hospitals ofKlebsiella pneumoniae serotype K25 harbouring a new transferable enzymatic resistance to third generation cephalosporins and aztreonamEuropean Journal of Clinical Microbiology & Infectious Diseases, 1988
- Towards a fundamental understanding of the MIC of β-lactam antibioticsJournal of Antimicrobial Chemotherapy, 1988
- Genetic Control of -Lactamase Production in Enterobacter cloacaeClinical Infectious Diseases, 1988
- Cefpirome (HR810) disk diffusion susceptibility tests: Confirmation of interpretive criteria using cefotaxime and cefoperazone-resistant strains and effects of blood supplemented mediaDiagnostic Microbiology and Infectious Disease, 1986
- Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mpl8 and pUC19 vectorsGene, 1985
- Electrophoretic resolution of the ‘major outer membrane protein’ of Escherichia coli K12 into four bandsFEBS Letters, 1975